citric acid, anhydrous has been researched along with Infections in 13 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Infections: Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Scintigraphic imaging of infection and inflammation is a powerful diagnostic tool in the management of patients with infectious or inflammatory diseases." | 2.41 | Radiopharmaceuticals for scintigraphic imaging of infection and inflammation. ( Boerman, OC; Corstens, FH; Dams, ET; Oyen, WJ; Storm, G, 2001) |
| "Nuclear medicine imaging of infection has two major indications: (a) the localization of a focus of infection in patients with fever of unknown origin; in this context the radio-pharmaceutical should be highly sensitive whereas specificity is not so important because subsequent biopsy or morphologically based imaging can be performed; (b) the diagnosis of an infection in patients with localized symptoms, for example after surgery, when normal anatomy is absent or when metal implants prevent computed tomography or magnetic resonance imaging." | 2.39 | The contribution of nuclear medicine to the patient with infection. ( Becker, W, 1995) |
| "There were 22 line infections and in approximately 70% of cases the infection was associated with a reduction in platelet count." | 1.34 | Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura. ( Berryman, J; Flynn, M; Longair, I; Machin, SJ; Scully, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Zarbock, A | 2 |
| Küllmar, M | 2 |
| Kindgen-Milles, D | 2 |
| Wempe, C | 2 |
| Gerss, J | 2 |
| Brandenburger, T | 1 |
| Dimski, T | 1 |
| Tyczynski, B | 1 |
| Jahn, M | 1 |
| Mülling, N | 1 |
| Mehrländer, M | 1 |
| Rosenberger, P | 1 |
| Marx, G | 2 |
| Simon, TP | 1 |
| Jaschinski, U | 1 |
| Deetjen, P | 1 |
| Putensen, C | 1 |
| Schewe, JC | 1 |
| Kluge, S | 2 |
| Jarczak, D | 1 |
| Slowinski, T | 2 |
| Bodenstein, M | 1 |
| Meybohm, P | 1 |
| Wirtz, S | 1 |
| Moerer, O | 1 |
| Kortgen, A | 1 |
| Simon, P | 1 |
| Bagshaw, SM | 1 |
| Kellum, JA | 1 |
| Meersch, M | 2 |
| HUDOCK, AE | 1 |
| BERRY, LJ | 1 |
| Dogra, GK | 1 |
| Herson, H | 1 |
| Hutchison, B | 1 |
| Irish, AB | 1 |
| Heath, CH | 1 |
| Golledge, C | 1 |
| Luxton, G | 1 |
| Moody, H | 1 |
| DOUJAK, PH | 1 |
| HUEBER, EF | 1 |
| SPITZY, KH | 1 |
| WOEHLER, F | 1 |
| Scully, M | 1 |
| Longair, I | 1 |
| Flynn, M | 1 |
| Berryman, J | 1 |
| Machin, SJ | 1 |
| Becker, W | 1 |
| Boerman, OC | 1 |
| Dams, ET | 1 |
| Oyen, WJ | 2 |
| Corstens, FH | 2 |
| Storm, G | 1 |
| Claessens, RA | 1 |
| van der Meer, JW | 1 |
| Oates, E | 1 |
| Ramberg, K | 1 |
| Lütten, C | 1 |
| Thomas, W | 1 |
| Dihlmann, W | 1 |
| Vorne, M | 1 |
| Soini, I | 1 |
| Lantto, T | 1 |
| Paakkinen, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Filters Useful Life, Metabolic Control, Electrolyte Profile and Acid-base Balance During Regional Anticoagulation With 4% Trisodium Citrate in Patients Undergoing CVVHDF: Effects of Increased Blood Flow[NCT05796661] | 27 participants (Anticipated) | Interventional | 2023-01-09 | Recruiting | |||
| Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy During Veno-venous ECMO: a Crossover Randomized Controlled Study[NCT05148026] | 20 participants (Anticipated) | Interventional | 2021-11-14 | Recruiting | |||
| Regional Citrate Versus Systemic Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury[NCT02669589] | Phase 4 | 638 participants (Actual) | Interventional | 2016-03-31 | Completed | ||
| Prismaflex Therapeutic Plasma Exchange: Evaluation of Complication Rates Using Filter vs. Centrifuge and Heparin vs. Citrate Anticoagulation[NCT04351438] | 108 participants (Actual) | Observational | 2012-01-31 | Active, not recruiting | |||
| [NCT00294502] | Phase 4 | 120 participants | Interventional | 2003-09-30 | Completed | ||
| Short Daily Alcohol Locks for the Prevention of Tunneled Catheter Infection in Patients With Haematological Disease. Randomised Placebo Controlled Trial[NCT00122642] | Phase 2/Phase 3 | 440 participants (Anticipated) | Interventional | 2005-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for citric acid, anhydrous and Infections
| Article | Year |
|---|---|
The contribution of nuclear medicine to the patient with infection.
Topics: Citrates; Citric Acid; Fever of Unknown Origin; Gallium Radioisotopes; Humans; Indium Radioisotopes; | 1995 |
Radiopharmaceuticals for scintigraphic imaging of infection and inflammation.
Topics: Antibodies; Citric Acid; Gallium Radioisotopes; Granulocytes; Humans; Immunoglobulin G; Infections; | 2001 |
[Human aspecific gamma globulin labeled with Indium 111: a new radiopharmaceutic agents for the localization of inflammation and infection foci].
Topics: Antibodies, Monoclonal; Citrates; Citric Acid; Gallium Radioisotopes; Humans; Indium Radioisotopes; | 1992 |
Imaging of intrathoracic disease with indium 111-labeled leukocytes.
Topics: Citrates; Citric Acid; Humans; Indium Radioisotopes; Infections; Leukocytes; Radionuclide Imaging; T | 1990 |
3 trials available for citric acid, anhydrous and Infections
6 other studies available for citric acid, anhydrous and Infections
| Article | Year |
|---|---|
Tissue citric acid and susceptibility to infection in mice duringchronic hypoxia and fluoroacetate poisoning.
Topics: Animals; Biochemical Phenomena; Citrates; Citric Acid; Disease Susceptibility; Fluoroacetates; Hypox | 1960 |
[Comparative studies with achromycin and additions of sodium phosphate or citric acid].
Topics: Anti-Bacterial Agents; Citric Acid; Infections; Phosphates; Tetracycline | 1958 |
STUDIES ON THE METABOLISM OF FE59 IRON-SORBITOL COMPLEX IN INFECTION.
Topics: Animals; Citric Acid; Drug Combinations; Ferric Compounds; Infections; Iron; Iron Isotopes; Rabbits; | 1964 |
Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura.
Topics: Acute Disease; Citric Acid; Detergents; Humans; Hypersensitivity; Infections; Plasma; Plasma Exchang | 2007 |
[Does technetium scintigraphy in combination with gallium scintigraphy improve the differential diagnosis of aseptic and septic endoprosthesis loosening?].
Topics: Aged; Aged, 80 and over; Citrates; Citric Acid; Diagnosis, Differential; Hip Prosthesis; Humans; Inf | 1989 |
Technetium-99m HM-PAO-labeled leukocytes in detection of inflammatory lesions: comparison with gallium-67 citrate.
Topics: Abdomen; Abscess; Adult; Aged; Blood Vessel Prosthesis; Bone Neoplasms; Citrates; Citric Acid; Femal | 1989 |